Status:
NOT_YET_RECRUITING
AI-Driven Early Warning System for Perioperative Risks in Acute Hemorrhagic Stroke
Lead Sponsor:
Beijing Tiantan Hospital
Conditions:
Acute Hemorrhagic Stroke
Eligibility:
All Genders
18-80 years
Brief Summary
Acute hemorrhagic cerebrovascular disease is a life-threatening condition characterized by sudden onset, rapid progression, multiple complications, poor prognosis, and high mortality. It presents a si...
Eligibility Criteria
Inclusion
- Patients aged 18 to 80 years.
- Diagnosis confirmed by preoperative imaging (CT or MRI) of one of the following conditions:
- Intracranial aneurysm
- Arteriovenous malformation (AVM)
- Hemorrhagic moyamoya disease
- Cavernous malformation
- Spontaneous intracerebral hemorrhage
- Undergoing surgery within seven days of symptom onset.
Exclusion
- Patients who decline to provide informed consent.
- Patients enrolled in conflicting clinical studies.
Key Trial Info
Start Date :
July 6 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
1533 Patients enrolled
Trial Details
Trial ID
NCT06998082
Start Date
July 6 2025
End Date
December 31 2028
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China, 100070